Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Immunome Inc (IMNM)

Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immunome Inc 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 USA

www.immunome.com Employees: 55 P: 425-939-7410

Description:

Immunome, Inc. is a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. Immunome, Inc. is based in Exton, United States.

Key Statistics

Overview:

Market Capitalization, $K 684,714
Enterprise Value, $K 586,034
Shares Outstanding, K 62,417
Annual Sales, $ 14,020 K
Annual Net Income, $ -106,810 K
Last Quarter Sales, $ 2,910 K
Last Quarter Net Income, $ -47,100 K
EBIT, $ -236,680 K
EBITDA, $ -236,460 K
60-Month Beta 1.83
% of Insider Shareholders 8.60%
% of Institutional Shareholders 44.58%
Float, K 57,049
% Float 91.40%
Short Volume Ratio 0.62

Growth:

1-Year Return 32.97%
3-Year Return -33.52%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.78 on 11/13/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -2.15
EPS Growth vs. Prev Qtr -59.18%
EPS Growth vs. Prev Year -116.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IMNM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -48.63%
Return-on-Assets % -41.62%
Profit Margin % -761.84%
Debt/Equity 0.00
Price/Sales 49.34
Price/Cash Flow N/A
Price/Book 3.10
Book Value/Share 3.58
Interest Coverage -4.43
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar